A detailed history of Convergence Investment Partners, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 1,954 shares of NTRA stock, worth $329,151. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,954
Previous 2,796 30.11%
Holding current value
$329,151
Previous $302,000 17.88%
% of portfolio
0.07%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$97.75 - $129.67 $82,305 - $109,182
-842 Reduced 30.11%
1,954 $248,000
Q2 2024

Aug 01, 2024

BUY
$85.28 - $112.6 $238,442 - $314,829
2,796 New
2,796 $302,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Convergence Investment Partners, LLC Portfolio

Follow Convergence Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.